MGA031
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MGA031, covering 2011-09-21 to 2023-12-05. Get the full timeline:
Most recent: Clinical Trial Update: The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus [Phase 2, Phase 3]